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PHOTOLON ENHANCEMENT OF ULTRASOUND CYTOTOXICITY
D.A. Tserkovsky, E.N. Alexandrova, Yu. Р. Istomin*
N.N. Alexandrov National Cancer Center of Belarus, 223040 Minsk, Belarus
Objective: To evaluate the impact of Photolon on cytostatic and cytotoxic effects of therapeutic range ultrasound in C6 glioma cells. 
Methods: C6 glioma cells in suspension or monolayer cell culture were exposed to ultrasound (880 kHz, 0.2-0.7 W/cm2) in the presence 
or absence of Photolon at the concentration of 1 μg/ml in the culture medium, and then cell viability was evaluated. Results: Photolon 
increased the cytotoxic effect of ultrasound by 1.5-2.3-fold but had no effect on its cytostatic activity. Conclusion: Photolon produces 
a pronounced sonosensitizing effect on glioma C6 cells and is a promising drug for sonodynamic treatment of malignant tumors.
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Ultrasound is widely used in medicine for diagnosis 
and treatment of many diseases. The use of ultra-
sound for therapeutic purposes is based on the spe-
cific nature of the interaction between ultrasound and 
biological tissues. Structural and functional changes 
in biological tissues exposed to ultrasound depend 
on the parameters of ultrasonic radiation: its frequency, 
intensity and duration of exposure. High-frequency 
ultrasound (1.0—31.5 MHz) is characterized by pre-
dominant thermal effect, whereas ultrasound with 
low frequency produces cavitation. Physiotherapeutic 
practice uses ultrasonic waves with 800 to 3000 kHz 
frequency and up to 3 W/cm2 intensity.
Investigation of biological effects of ultrasonic 
waves with different frequency, intensity and duration 
of action has shown that ultrasound exerts antitumor 
activity. In experimental studies, ultrasound of thera-
peutic range was found to cause growth inhibition and 
death of human tumor cells: leukemia K562, HL-60, 
KG1a and Nalm-6 cells [1, 2], breast adenocarcinoma 
MCF-7 cells, ovarian carcinoma SC-OV-3 [3], epider-
moid cancer [4], cervical carcinoma HeLa cells [5–7], 
colon carcinoma HT-29 cells, gingival carcinoma 
Ca9-22 cells [7], glioma C6 cells [8, 9], as well as im-
planted rat tumors: Zeidel hepatoma, M-1 sarcoma 
[4], RS-1 cholangiocellular carcinoma [10], C6 glioma 
[11]. High-intensity (3 W/cm2 to 104 W/cm2) focused 
ultrasound with 1—10 MHz frequency, the absorption 
of which results in a focal temperature of 40—100 °C, 
is used in oncology for non-invasive surgery of deep-
seated tumors, as well as for induction of local hy-
perthermia.
Moreover, exposure to ultrasound of a specific 
frequency range, intensity and duration was found 
to improve the efficacy of anticancer drugs both in vitro 
and in vivo without causing direct destruction of tumor 
cells, which is attributed to increased permeability 
of cell membranes for cytostatics [10, 12]. The poten-
tial gain in radiosensitivity of tumor cells due to ultra-
sound pretreatment was also demonstrated [13, 14].
A new trend, sonodynamic therapy of malignant 
tumors is being developed, which is based on tumor 
destruction as a result of synergetic enhancement 
of ultrasound effect by a sonosensitizer drug. The 
terms “sonodynamic therapy” and “sonosensitizer” 
were proposed by Umemura et al.(1990) by anal-
ogy with the terms of photodynamic therapy, as the 
classical photosensitizer hematoporphyrin had also 
been shown to possess sonosensitizing properties 
[15]. The mechanism of sonodynamic therapy seems 
to be associated with the damage of cell membranes. 
The advantage of sonodynamic therapy over photody-
namic one is its ability to focus ultrasound in the area 
of deep-seated tumors.
In experimental models in vitro on tumor cells 
and in vivo on transplanted tumors in laboratory 
animals, the sonosensitizing properties of porphyrin 
photosensitizers and a number of other compounds 
were studied [12]. Such photosensitizers as hema-
toporphyrin, Photofrin, Photofrin II, mesoporfirin, 
protoporphyrin, protoporphyrin IX, TPPS, ATX-70, 
ATX-S10, pheophorbide-a, AlPcS4, chlorine PAD-
S31 [15], methylene blue [16], erythrosine, rhodamine 
[17], NPe6 [18], rose bengal [11], 5-ALA [19], chlorin 
e6 [20] have been shown to enhance ultrasound cy-
totoxic effect on tumor cells and implanted tumors. 
The results of the experimental studies suggest that 
sonodynamic therapy is a promising treatment modal-
ity for malignant tumors.
The purpose of this study was to investigate a so-
nodynamic activity of the original Belarusian photo-
sensitizer Photolon.
The study was conducted on C6 rat glioma cell line 
(Russian Collection of Cell Cultures, Cytology Institute 
of Russian Academy of Sciences, St. Petersburg). The 
cells were cultured in DMEM culture medium supple-
mented with 10% fetal calf serum.
Exponentially growing cells as a monolayer or sus-
pension culture were used for the experiments. To sus-
pend the cells, the monolayer was detached from the 
culture flasks with 0.02% versen.
The drug Photolon (RUE Belmedpreparaty, Be-
larus) was diluted with saline just before the use.
The cells were sonicated with ultrasound of 0.2, 
0.4 or 0.7 W/cm2 intensity at room temperature for 
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60 s, using UST-1.040 apparatus for ultrasonic therapy 
(880 kHz, EMA Plant, Russia) in the continuous ul-
trasonic generation mode. The emitter was placed 
directly into the culture medium.
Photolon (1 μg/ml) was added to the culture me-
dium 5 min before sonication of the cell suspension 
or 2 h before sonication of the cell monolayer (for 
maximum accumulation of Photolon in the cells).
The cytotoxic effect of ultrasound on C6 glioma 
cells in the suspension was assessed by trypan blue 
dye exclusion test 5 min after the exposure.
To evaluate the cytostatic effect of ultrasound, 
the monolayer culture growth of C6 glioma cells after 
the treatment was studied. 24 h after sonication, the 
monolayer was detached from the culture flasks with 
0.02% versen, and viable (trypan blue unstained) 
cells were counted in a hemocytometer. The increase 
in the cell number compared to the control value was 
calculated from: (Nt-No)/(Nc-No) if Nt was greater 
than or equal to No, or (Nt-No)/No, if Nt was less than 
No (Nt — cell number in the treated culture; Nc — cell 
number in the control culture; No — initial cell number 
before the treatment).
The values of II50, ultrasound intensity required 
for a 50% inhibition of cell proliferation, and LI50, 
ultrasound intensity required for a 50% cell death, 
were calculated using regression analysis of the data 
obtained. The enhancement ratio (ER) for inhibi-
tion of cell proliferation or cell killing was calculated 
as II50 or LI50 for ultrasound without Photolon divided 
by II50 or LI50 for ultrasound with Photolon.
The values obtained were processed using stan-
dard statistical methods of Origin 7.0.
To assess the cytotoxic effect of ultrasound, C6 gli-
oma cell suspension (785 × 103 cells/ml) was sonicated 
at 0.2, 0.4 or 0.7 W/cm2 ultrasound intensity. Then the 
number of viable cells was calculated by trypan blue 
dye exclusion test.
Fig. 1, a, presents the number of viable C6 cells 
in suspension after the exposure to ultrasound alone 
or in combination with Photolon. The results suggest 
that sonication leads to a decrease in the number of vi-
able cells. The cell death increased with ultrasound 
intensity; LI50, ultrasound intensity required for a 50% 
cell death, was 0.51 W/cm2.
Photolon addition to the cell suspension resulted 
in a significant enhancement of ultrasound cytotoxic-
ity at 0.4 and 0.7 W/cm2 intensity, with LI50 decreasing 
to 0.33 W/cm2. The differences in cell number after 
the exposure to ultrasound alone and ultrasound with 
Photolon were statistically significant (p < 0.01). Thus, 
the gain in ultrasound cytotoxicity in the presence 
of Photolon was 1.5.
It should be noted that Photolon alone caused 
a decrease in the number of viable cells only by 16% 
compared to the control. The temperature of the 
culture medium during cell treatment with ultrasound 
did not rise.
The effect of varying intensity ultrasound on the 
growth of the monolayer culture of C6 glioma cells 
was assessed by the number of viable cells 24 h after 
the exposure.
The data presented in Fig. 1, b, suggest that soni-
cation leads to growth inhibition of C6 glioma cells, 
the number of viable cells reducing with increased 
ultrasound intensity. Regression analysis of the data 
revealed that II50, the ultrasound intensity needed for 
a 50% inhibition of cell proliferation, was 0.27 W/cm2, 
and LI50, the ultrasound intensity required for a 50% 
cell death, was 1.32 W/cm2.
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Fig. 1. Effect of ultrasound alone or in combination with Pho-
tolon on the number of viable C6 glioma cells in suspension (a) 
or in monolayer (b)
Photolon addition to the culture medium before 
sonication resulted in an enhanced effect of ultrasound 
on C6 cell monolayer, the number of viable cells after 
the exposure being statistically significantly lower 
(p < 0.01) than after ultrasound alone (Table). II50 was 
0.28 W/cm2, and LI50 was 0.58 W/cm2. Thus, Photolon 
did not intensify growth inhibition of monolayer cell 
cultures after sonication. But cell death increased 
2.3-fold when ultrasound was combined with Photolon 
compared to the effect of ultrasound alone. It should 
be noted that Photolon alone had almost no effect 
on the growth of C6 glioma cell cultures, the number 
of viable cells reducing by 8% compared to the control.
Table. Cytostatic and cytotoxic effect of ultrasound (W/cm2) on C6 cells
Treatment
Cell culture
Suspension Monolayer
II50 LI50 II50 LI50
US - 0.51±0.03 0.27±0.03 1.32±0.03
US+Photolon - 0.33±0.03
(ER=1.5)
0.28±0.02
(ER=1.0)
0.58±0.02
(ER=2.3)
Photodynamic therapy with various photosensitiz-
ers including Photolon is currently used in multimo-
dality treatment of malignant gliomas. The original 
photosensitizer Photolon, a complex of chlorin e6 salt 
Experimental Oncology 33, 107–109, 2011 (June) 109
and polyvinylpyrrolidone, is selectively accumulated 
in tumor tissues, displays strong photodynamic activity 
and is registered as an agent for photodynamic therapy 
of malignant neoplasms. Photolon is able to penetrate 
the blood-brain barrier, and it may be used for intraop-
erative photodynamic therapy in patients with primary 
and metastatic brain tumors [21].
The feasibility of sonodynamic therapy of glial brain 
tumors is under study. Indeed, sonodynamic activity 
of hematoporphyrin [8, 9] and rose bengal [11] pho-
tosensitizers in experimental models of glioma in vitro 
and in vivo has been investigated. The authors have 
reported pronounced antitumor efficacy of ultrasound 
in combination with these photosensitizers in the treat-
ment of experimental malignant gliomas.
The results of our study on C6 glioma cells suggest 
that Photolon also displays pronounced sonosensitiz-
ing activity and is a promising drug for sonodynamic 
treatment of gliomas.
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